文献速递主动脉疾病

EVAR是治疗原发性感染性腹主动脉瘤的可行策略

Endovascular Aortic Repair Is a Viable Strategy for Treatment of Primary Infected Abdominal Aortic Aneurysm.
PubMed 文献 · Ann Vasc Surg · 2019-02-22

择期EVAR的短期和长期结果可接受,且抗生素治疗第一周ESR下降幅度与动脉瘤破裂及EVAR后生存时间相关。

要点

  • 择期EVAR治疗感染性腹主动脉瘤的短期和长期结果可接受。
  • 抗生素治疗第一周ESR下降幅度与动脉瘤破裂风险呈负相关。
  • ESR下降小于0.130可能提示动脉瘤破裂风险。

核心结论

  • 择期EVAR治疗感染性腹主动脉瘤具有可接受的短期和长期结局。
  • 患者对初始抗生素治疗的反应可能有助于指导治疗决策。

研究设计与样本

  • 患者在接受辅助抗生素治疗后,分别接受急诊开放修复、急诊EVAR或择期EVAR。

主要发现

  • 12例患者获得阳性微生物培养结果。
  • 急诊EVAR组、开放修复组和择期EVAR组的30天死亡率分别为16.7%(1/6)、0%和0%。
  • 急诊EVAR组、开放修复组和择期EVAR组的1年生存率分别为16.7%(1/6)、100%(1/1)和88.9%(8/9)。
  • 平均随访时间28.8个月(范围1.5-96个月)。
  • 抗生素治疗第一周ESR下降与动脉瘤破裂呈负相关,并与EVAR后生存时间相关。

关键数值与推荐

  • 抗生素治疗第一周ESR下降小于0.130可能提示动脉瘤破裂风险。

临床怎么用

  • 对于原发性感染性腹主动脉瘤,择期EVAR可作为治疗选择之一。
  • 初始抗生素治疗期间监测ESR变化有助于评估破裂风险和指导治疗策略。

局限性

  • 各组样本量不均,急诊开放修复组仅3例,择期EVAR组10例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infected abdominal aortic aneurysm (IAAA) is rare, and information is limited whether endovascular aortic repair (EVAR) can be considered a permanent treatment or is a temporary fix preceding open surgery. This retrospective study reviewed the short- and long-term outcomes of open surgery, emergent EVAR, and elective EVAR in the treatment of primary IAAA. METHODS: Between January 2008 and January 2017, 16 men and 3 women (aged 60.7 y; range 30-76 y) with IAAA were treated with emergent open repair, emergent EVAR, or elective EVAR, after adjunctive antibiotic therapy. Demographics, aneurysm anatomy, clinical presentations, laboratory tests, details of aneurysm repair, morbidity, mortality, and postoperative outcomes of these patients were reviewed. RESULTS: Positive microbial cultures were obtained in 12 patients. Six and 3 patients underwent emergent EVAR and open repair, respectively. Ten patients who completed the full antibiotic regimen received elective EVAR. The mean follow-up duration was 28.8 mo (range, 1.5-96 mo). The 30-day mortality rates of the emergent EVAR, open repair, and elective EVAR groups were 16.7% (1/6), 0%, and 0%, respectively; the 1-year survival rates were 16.7% (1/6), 100% (1/1), and 88.9% (8/9). Reduction in the blood erythrocyte sedimentation rate (ESR) during the first week of antibiotic treatment was inversely related to aneurysm rupture and correlated with patients' post-EVAR survival time. CONCLUSIONS: Elective EVAR for IAAA had acceptable short- and long-term outcomes. Patients' response to initial antibiotic treatment may help facilitate management. Less than 0.130 reduction in ESR during the first week of antibiotic treatment may indicate risk of aneurysm rupture.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Di X, Liu C, Zeng R, et al. Endovascular Aortic Repair Is a Viable Strategy for Treatment of Primary Infected Abdominal Aortic Aneurysm. Ann Vasc Surg. 2019. PMID: 30802582. doi:10.1016/j.avsg.2018.12.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。